Skip to content
Insider tapeLive · 3:49 PM ET
My stocks
✦ Spy Mode investigation

Robert Nelsen's $3.1M purchase of CTY

CITY THERAPEUTICS, INC. · Director · filed Oct 19, 2026. Opened Oct 28, 2026, last checked Oct 28, 2026. 7-day result in; next check Nov 18, 2026.

Reported value$3.1M170,000 shares at $18.00
For this personUnusual1 buy · 0 sales on file
Similar buys beat S&P45%1,823 cases · all buys 46%

Worth a closer look

  • Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.

Reasons for caution

  • Held indirectly (a trust, fund or family entity), so the economic owner isn't only the named insider.
  • Small next to what they already own (holding up 1.3%).
  • Similar past buys beat the S&P 500 only 45% of the time (1,823 cases); the typical one trailed it by 1.8%.
  • Their past buys: only 1 of 3 beat the S&P 500.

What happened after this filing

7 days -3.1% -3.0% vs S&P
30 days Pending due Nov 18
90 days Pending due Jan 17

What we couldn't check

  • Why they traded. Filings don't say, and we don't guess.
  • Company news after the filing, and any private terms.
Summary

Robert Nelsen (a director) bought $3.1M of CTY at about $18.00 on Oct 19, 2026, reported to the SEC on Oct 19, 2026. Buys like this beat the S&P 500 45% of the time since 2020, against 46% for all insider buys. We found 1 point that make it worth a closer look and 4 reasons for caution. History, not a prediction.

Share on X Bluesky Reddit

Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.

Other CTY insider trades

Get CTY insider alerts

Choose what you want to hear about. Free.

You'll get an email when a new CTY filing matches your choices (at most one per alert type a day), plus the free Monday email. Already subscribed? Use the same email to add CTY. Unsubscribe anytime. No price targets or advice.

More investigations

All →